Immunomodulatory effects of β-defensin 2 on tumor associated macrophages induced antitumor function in breast cancer

Background: Tumor-associated macrophages (TAMs) express cytokines and chemokines that can suppress antitumor immunity and promote tumor progression. The immunomodulatory and antitumor function of β-defensin 2 is still unclear, despite the evidence of infection response. We previously reported that β...

Full description

Bibliographic Details
Main Authors: Sonam Agarwal, Anita Chauhan, Pramod Kumar Gautam
Format: Article
Language:English
Published: Elsevier 2023-07-01
Series:Advances in Cancer Biology - Metastasis
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2667394023000163
_version_ 1827921372592996352
author Sonam Agarwal
Anita Chauhan
Pramod Kumar Gautam
author_facet Sonam Agarwal
Anita Chauhan
Pramod Kumar Gautam
author_sort Sonam Agarwal
collection DOAJ
description Background: Tumor-associated macrophages (TAMs) express cytokines and chemokines that can suppress antitumor immunity and promote tumor progression. The immunomodulatory and antitumor function of β-defensin 2 is still unclear, despite the evidence of infection response. We previously reported that β-defensin 2 modulates immunomodulatory and their antitumor function of macrophages in breast cancer. We investigate the association between β-defensin 2 and TAMs and determined the role in tumor-promoting attributes of TAMs reversal of phenotype in tumor regression. Methods: Swiss albino mice and C127i breast cancer cell line was used in this study. C127i conditioned media was prepared and generated macrophage-derived TAMs to study antitumor function. Flow cytometry was performed for phenotype identification of macrophages and TAMs. MTT assay was performed to estimate cytotoxicity and dose optimization of β-defensin 2. Oxidative stress was analyzed by H2O2 and NO estimation, and qPCR was performed for iNOS, cytokines and chemokines expression. Results: PEC harvested macrophages were characterized by flow-cytometry using F4/80, CD11c antibodies with 98% pure population of macrophages and cultured in C127i conditioned media for 7 days. TAMs markers were estimated, and it was found that 98% expression of F4/80, CD-206, and CD-115 expression compared to macrophages. Purified 100 ng/ml of β-defensin 2 was used to stimulate the TAMs population was viable, which was confirmed by cell viability assay. ROS levels decreased in TAMs treated with β-defensin 2 compared to control group. Interleukins (ILs)-6, 10, and 3, tumor necrosis factor (TNF)-α, and transforming growth factor (TGF)-β and chemokine ligand (CXCL)-1, 5 and 15, chemokine ligand (CCL)-24 and 5 decreased drastically compared to control. Conclusion: This is the first report of β-defensin 2 on TAMs to elucidate the immunomodulatory and anti-tumor function. It was found that the cytokines, chemokines, and reactive oxygen species (ROS) expression pliably changed which facilitates tumor regression. β-defensin 2 must be targets as adjuvant for future cancer immunotherapeutic agent.
first_indexed 2024-03-13T04:25:34Z
format Article
id doaj.art-2298134dd2a24dae92d2a9b7a9c9be5b
institution Directory Open Access Journal
issn 2667-3940
language English
last_indexed 2024-03-13T04:25:34Z
publishDate 2023-07-01
publisher Elsevier
record_format Article
series Advances in Cancer Biology - Metastasis
spelling doaj.art-2298134dd2a24dae92d2a9b7a9c9be5b2023-06-20T04:21:30ZengElsevierAdvances in Cancer Biology - Metastasis2667-39402023-07-017100102Immunomodulatory effects of β-defensin 2 on tumor associated macrophages induced antitumor function in breast cancerSonam Agarwal0Anita Chauhan1Pramod Kumar Gautam2Department of Biochemistry, AIIMS, New Delhi, 110029, IndiaDepartment of Biochemistry, AIIMS, New Delhi, 110029, IndiaCorresponding author. Dept. of Biochemistry, AIIMS, New Delhi, 110029, India.; Department of Biochemistry, AIIMS, New Delhi, 110029, IndiaBackground: Tumor-associated macrophages (TAMs) express cytokines and chemokines that can suppress antitumor immunity and promote tumor progression. The immunomodulatory and antitumor function of β-defensin 2 is still unclear, despite the evidence of infection response. We previously reported that β-defensin 2 modulates immunomodulatory and their antitumor function of macrophages in breast cancer. We investigate the association between β-defensin 2 and TAMs and determined the role in tumor-promoting attributes of TAMs reversal of phenotype in tumor regression. Methods: Swiss albino mice and C127i breast cancer cell line was used in this study. C127i conditioned media was prepared and generated macrophage-derived TAMs to study antitumor function. Flow cytometry was performed for phenotype identification of macrophages and TAMs. MTT assay was performed to estimate cytotoxicity and dose optimization of β-defensin 2. Oxidative stress was analyzed by H2O2 and NO estimation, and qPCR was performed for iNOS, cytokines and chemokines expression. Results: PEC harvested macrophages were characterized by flow-cytometry using F4/80, CD11c antibodies with 98% pure population of macrophages and cultured in C127i conditioned media for 7 days. TAMs markers were estimated, and it was found that 98% expression of F4/80, CD-206, and CD-115 expression compared to macrophages. Purified 100 ng/ml of β-defensin 2 was used to stimulate the TAMs population was viable, which was confirmed by cell viability assay. ROS levels decreased in TAMs treated with β-defensin 2 compared to control group. Interleukins (ILs)-6, 10, and 3, tumor necrosis factor (TNF)-α, and transforming growth factor (TGF)-β and chemokine ligand (CXCL)-1, 5 and 15, chemokine ligand (CCL)-24 and 5 decreased drastically compared to control. Conclusion: This is the first report of β-defensin 2 on TAMs to elucidate the immunomodulatory and anti-tumor function. It was found that the cytokines, chemokines, and reactive oxygen species (ROS) expression pliably changed which facilitates tumor regression. β-defensin 2 must be targets as adjuvant for future cancer immunotherapeutic agent.http://www.sciencedirect.com/science/article/pii/S2667394023000163β-defensin 2TAMsCytokinesChemokinesROSBreast cancer
spellingShingle Sonam Agarwal
Anita Chauhan
Pramod Kumar Gautam
Immunomodulatory effects of β-defensin 2 on tumor associated macrophages induced antitumor function in breast cancer
Advances in Cancer Biology - Metastasis
β-defensin 2
TAMs
Cytokines
Chemokines
ROS
Breast cancer
title Immunomodulatory effects of β-defensin 2 on tumor associated macrophages induced antitumor function in breast cancer
title_full Immunomodulatory effects of β-defensin 2 on tumor associated macrophages induced antitumor function in breast cancer
title_fullStr Immunomodulatory effects of β-defensin 2 on tumor associated macrophages induced antitumor function in breast cancer
title_full_unstemmed Immunomodulatory effects of β-defensin 2 on tumor associated macrophages induced antitumor function in breast cancer
title_short Immunomodulatory effects of β-defensin 2 on tumor associated macrophages induced antitumor function in breast cancer
title_sort immunomodulatory effects of β defensin 2 on tumor associated macrophages induced antitumor function in breast cancer
topic β-defensin 2
TAMs
Cytokines
Chemokines
ROS
Breast cancer
url http://www.sciencedirect.com/science/article/pii/S2667394023000163
work_keys_str_mv AT sonamagarwal immunomodulatoryeffectsofbdefensin2ontumorassociatedmacrophagesinducedantitumorfunctioninbreastcancer
AT anitachauhan immunomodulatoryeffectsofbdefensin2ontumorassociatedmacrophagesinducedantitumorfunctioninbreastcancer
AT pramodkumargautam immunomodulatoryeffectsofbdefensin2ontumorassociatedmacrophagesinducedantitumorfunctioninbreastcancer